Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 2748340, 17 pages
https://doi.org/10.1155/2017/2748340
Review Article

Biophysical Mechanisms Mediating Fibrin Fiber Lysis

Department of Physics, East Carolina University, N304 Howell Science Complex, Greenville, NC 27858, USA

Correspondence should be addressed to Nathan E. Hudson; ude.uce@61nnosduh

Received 3 February 2017; Accepted 30 April 2017; Published 28 May 2017

Academic Editor: Robert A. S. Ariens

Copyright © 2017 Nathan E. Hudson. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Liu, L. M. Jawerth, E. A. Sparks et al., “Fibrin fibers have extraordinary extensibility and elasticity,” Science, vol. 313, no. 5787, article 634, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. A. E. X. Brown, R. I. Litvinov, D. E. Discher, P. K. Purohit, and J. W. Weisel, “Multiscale mechanics of fibrin polymer: gel stretching with protein unfolding and loss of water,” Science, vol. 325, no. 5941, pp. 741–744, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Varjú, P. Sótonyi, R. Machovich et al., “Hindered dissolution of fibrin formed under mechanical stress,” Journal of Thrombosis and Haemostasis, vol. 9, no. 5, pp. 979–986, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Kluft, J. J. Sidelmann, and J. B. Gram, “Assessing safety of thrombolytic therapy,” Seminars in Thrombosis and Hemostasis, vol. 43, no. 3, pp. 300–310, 2016. View at Google Scholar
  5. S. T. Lord, “Fibrinogen and fibrin: scaffold proteins in hemostasis,” Current Opinion in Hematology, vol. 14, no. 3, pp. 236–241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. E. V. Lugovskoi, P. G. Gritsenko, and S. V. Komisarenko, “Molecular mechanisms of the polymerization of fibrin and the formation of its three-dimensional network,” Russian Journal of Bioorganic Chemistry, vol. 35, no. 4, pp. 393–410, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Z Zhang and C. M Redman, “Role of interchain disulfide bonds on the assembly and secretion of human fibrinogen,” Journal of Biological Chemistry, vol. 269, no. 1, pp. 652–658, 1994. View at Google Scholar
  8. G. Spraggon, S. J. Everse, and R. F. Doollttle, “Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin,” Nature, vol. 389, no. 6650, pp. 455–462, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Kollman, L. Pandi, M. R. Sawaya, M. Riley, and R. F. Doolittle, “Crystal structure of human fibrinogen,” Biochemistry, vol. 48, no. 18, pp. 3877–3886, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. R. F. Doolittle and J. M. Kollman, “Natively unfolded regions of the vertebrate fibrinogen molecule,” Proteins: Structure, Function and Genetics, vol. 63, no. 2, pp. 391–397, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Medved and J. W. Weisel, “Recommendations for nomenclature on fibrinogen and fibrin,” Journal of Thrombosis and Haemostasis, vol. 7, no. 2, pp. 355–359, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. I. Veklich, O. V. Gorkun, L. V. Medved, W. Nieuwenhuizen, and J. W. Weisel, “Carboxyl-terminal portions of the alpha chains of fibrinogen and fibrin. localization by electron microscopy and the effects of isolated alpha C fragments on polymerization,” The Journal of Biological Chemistry, vol. 268, no. 18, pp. 13577–13585, 1993. View at Google Scholar
  13. G. Tsurupa, R. R. Hantgan, R. A. Burton, I. Pechik, N. Tjandra, and L. Medved, “Structure, stability, and interaction of the fibrin(ogen) αC-domains,” Biochemistry, vol. 48, no. 51, pp. 12191–12201, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Tsurupa, I. Pechik, R. I. Litvinov et al., “On the mechanism of αc polymer formation in fibrin,” Biochemistry, vol. 51, no. 12, pp. 2526–2538, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. N. E. Hudson, F. Ding, I. Bucay et al., “Submillisecond elastic recoil reveals molecular origins of fibrin fiber mechanics,” Biophysical Journal, vol. 104, no. 12, pp. 2671–2680, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. R. I. Litvinov, S. Yakovlev, G. Tsurupa, O. V. Gorkun, L. Medved, and J. W. Weisel, “Direct evidence for specific interactions of the fibrinogen αC-domains with the central E region and with each other,” Biochemistry, vol. 46, no. 31, pp. 9133–9142, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. M. W. Mosesson, “Fibrinogen and fibrin structure and functions,” Journal of Thrombosis and Haemostasis, vol. 3, no. 8, pp. 1894–1904, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Medved and W. Nieuwenhuizen, “Molecular mechanisms of initiation of fibrinolysis by fibrin,” Thrombosis and Haemostasis, vol. 89, no. 3, pp. 409–419, 2003. View at Google Scholar
  19. J.-P. Collet, J. L. Moen, Y. I. Veklich et al., “The αC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis,” Blood, vol. 106, no. 12, pp. 3824–3830, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. J. W. Weisel, C. Nagaswami, and L. Makowski, “Twisting of fibrin fibers limits their radial growth,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 24, pp. 8991–8995, 1987. View at Google Scholar
  21. J.-P. Collet, H. Shuman, R. E. Ledger, S. Lee, and J. W. Weisel, “The elasticity of an individual fibrin fiber in a clot,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 26, pp. 9133–9137, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. W. A. Voter, C. Lucaveche, and H. P. Erickson, “Concentration of protein in fibrin fibers and fibrinogen polymers determined by refractive index matching,” Biopolymers, vol. 25, no. 12, pp. 2375–2384, 1986. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Yeromonahos, B. Polack, and F. Caton, “Nanostructure of the fibrin clot,” Biophysical Journal, vol. 99, no. 7, pp. 2018–2027, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. L. Diamond, “Engineering design of optimal strategies for blood clot dissolution,” Annual Review of Biomedical Engineering, no. 1, pp. 427–461, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. K. A. Leonidakis, P. Bhattacharya, J. Patterson et al., “Fibrin structural and diffusional analysis suggests that fibers are permeable to solute transport,” Acta Biomaterialia, vol. 47, pp. 25–39, 2017. View at Google Scholar
  26. J. Weisel and R. Litvinov, “The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate,” Cardiovascular & Hematological Agents in Medicinal Chemistry, vol. 6, no. 3, pp. 161–180, 2008. View at Google Scholar
  27. B. E. Bannish, J. P. Keener, and A. L. Fogelson, “Modelling fibrinolysis: a 3D stochastic multiscale model,” Mathematical Medicine and Biology. A Journal of the IMA, vol. 31, no. 1, pp. 17–44, 2014. View at Publisher · View at Google Scholar · View at MathSciNet
  28. C. E. Hall, “Electron microscopy of fibrinogen and fibrin,” The Journal of Biological Chemistry, vol. 179, no. 2, pp. 857–865, 1949. View at Google Scholar
  29. Z. Yang, I. Mochalkin, and R. F. Doolittle, “A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 26, pp. 14156–14161, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Guthold, W. Liu, B. Stephens et al., “Visualization and mechanical manipulations of individual fibrin fibers suggest that fiber cross section has fractal dimension 1.3,” Biophysical Journal, vol. 87, no. 6, pp. 4226–4236, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. W. Li, J. Sigley, M. Pieters et al., “Fibrin fiber stiffness is strongly affected by fiber diameter, but not by fibrinogen glycation,” Biophysical Journal, vol. 110, no. 6, pp. 1400–1410, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. I. K. Piechocka, R. G. Bacabac, M. Potters, F. C. Mackintosh, and G. H. Koenderink, “Structural hierarchy governs fibrin gel mechanics,” Biophysical journal, vol. 98, no. 10, pp. 2281–2289, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. I. Varjú, K. Tenekedjiev, Z. Keresztes et al., “Fractal kinetic behavior of plasmin on the surface of fibrin meshwork,” Biochemistry, vol. 53, no. 40, pp. 6348–6356, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. D. C. Rijken, M. Hoylaerts, and D. Collen, “Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator,” The Journal of Biological Chemistry, vol. 257, no. 6, pp. 2920–2925, 1982. View at Google Scholar
  35. S. Yakovlev, E. Makogonenko, N. Kurochkina, W. Nieuwenhuizen, K. Ingham, and L. Medved, “Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites,” Biochemistry, vol. 39, no. 51, pp. 15730–15741, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. W. J. G. Schielen, M. Voskuilen, G. I. Tesser, and W. Nieuwenhuizen, “The sequence Aα-(148-160) in fibrin, but not in fibrinogen, is accessible to monoclonal antibodies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 22, pp. 8951–8954, 1989. View at Publisher · View at Google Scholar · View at Scopus
  37. J. W. Weisel, C. Nagaswami, B. Korsholm, L. C. Petersen, and E. Suenson, “Interactions of plasminogen with polymerizing fibrin and its derivatives, monitored with a photoaffinity cross-linker and electron microscopy,” Journal of Molecular Biology, vol. 235, no. 3, pp. 1117–1135, 1994. View at Publisher · View at Google Scholar · View at Scopus
  38. P. J. Bosma, D. C. Rijken, and W. Nieuwenhuizen, “Binding of tissue‐type plasminogen activator to fibrinogen fragments,” European Journal of Biochemistry, vol. 172, no. 2, pp. 399–404, 1988. View at Publisher · View at Google Scholar · View at Scopus
  39. W. J. Schielen, H. P. Adams, K. van Leuven, M. Voskuilen, G. I. Tesser, and W. Nieuwenhuizen, “The sequence gamma-(312–324) is a fibrin-specific epitope,” Blood, vol. 77, no. 10, pp. 2169–2173, 1991. View at Google Scholar
  40. M. Hoylaerts, D. C. Rijken, H. R. Lijnen, and D. Collen, “Kinetics of the activation of plasminogen by human tissue plasminogen activator. role of fibrin,” Journal of Biological Chemistry, vol. 257, no. 6, pp. 2912–2919, 1982. View at Google Scholar
  41. J. Koopman, F. Haverkate, J. Grimbergen, R. Egbring, and S. T. Lord, “Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids A alpha 461–610 (Lys 461 AAA-->stop TAA),” Blood, vol. 80, no. 8, pp. 1972–1979, 1992. View at Google Scholar
  42. H. R. Lijnen, J. Soria, C. Soria, D. Collen, and J. P. Caen, “Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation,” Thrombosis and Haemostasis, vol. 51, no. 1, pp. 108-109, 1984. View at Google Scholar
  43. G. Tsurupa and L. Medved, “Identification and characterization of novel tPA- and plasminogen-binding sites within fibrin(ogen) αC-domains,” Biochemistry, vol. 40, no. 3, pp. 801–808, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. M. F. B. G. Gebbink, “Tissue-type plasminogen activator-mediated plasminogen activation and contact activation, implications in and beyond haemostasis,” Journal of Thrombosis and Haemostasis, vol. 9, supplement 1, pp. 174–181, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. K. A. Smith, P. J. Adamson, R. J. Pease et al., “Interactions between factor XIII and the αC region of fibrinogen,” Blood, vol. 117, no. 12, pp. 3460–3468, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Kimura and N. Aoki, “Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor,” Journal of Biological Chemistry, vol. 261, no. 33, pp. 15591–15595, 1986. View at Google Scholar
  47. A. Henschen and J. Mcdonagh, “Chapter 7 Fibrinogen, fibrin and factor XIII,” New Comprehensive Biochemistry, vol. 13, pp. 171–241, 1986. View at Publisher · View at Google Scholar · View at Scopus
  48. D. L. Higgins and G. A. Vehar, “Interaction of one-chain and two-chain tissue plasminogen activator with intact and plasmin-degraded fibrin,” Biochemistry, vol. 26, no. 24, pp. 7786–7791, 1987. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Collen, G. Tytgat, H. Claeys, M. Verstraete, and P. Wallén, “Metabolism of plasminogen in healthy subjects: effect of tranexamic acid,” Journal of Clinical Investigation, vol. 51, no. 6, pp. 1310–1318, 1972. View at Publisher · View at Google Scholar · View at Scopus
  50. M. L. Hayes and J. F. Castellino, “Carbohydrate of the human plasminogen variants. I. Carbohydrate composition, glycopeptide isolation, and characterization,” The Journal of Biological Chemistry, vol. 254, no. 18, pp. 8768–8771, 1979. View at Google Scholar
  51. M. L. Hayes and F. J. Castellino, “Carbohydrate of the human plasminogen variants. II. Structure of the asparagine-linked oligosaccharide unit,” The Journal of Biological Chemistry, vol. 254, no. 18, pp. 8772–8776, 1979. View at Google Scholar
  52. S. R. Pirie-Shepherd, R. D. Stevens, N. L. Andon, J. J. Enghild, and S. V. Pizzo, “Evidence for a novel O-linked sialylated trisaccharide on Ser-248 of human plasminogen 2,” Journal of Biological Chemistry, vol. 272, no. 11, pp. 7408–7411, 1997. View at Publisher · View at Google Scholar · View at Scopus
  53. G. L. Hortin, “Isolation of glycopeptides containing O-linked oligosaccharides by lectin affinity chromatography on jacalin-agarose,” Analytical Biochemistry, vol. 191, no. 2, pp. 262–267, 1990. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Gonzalez-Gronow, G. Gawdi, and S. V. Pizzo, “Tissue factor is the receptor for plasminogen type 1 on 1-LN human prostate cancer cells,” Blood, vol. 99, no. 12, pp. 4562–4567, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Takada, Y. Makino, and A. Takada, “Glu-plasminogen I and II: their activation by urokinase and streptokinase in the presence of fibrin and fibrinogen,” Thrombosis Research, vol. 39, no. 3, pp. 289–296, 1985. View at Publisher · View at Google Scholar · View at Scopus
  56. R. H. P. Law, T. Caradoc-Davies, N. Cowieson et al., “The X-ray crystal structure of full-length human plasminogen,” Cell Reports, vol. 1, no. 3, pp. 185–190, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Xue, C. Bodin, and K. Olsson, “Crystal structure of the native plasminogen reveals an activation-resistant compact conformation,” Journal of Thrombosis and Haemostasis, vol. 10, no. 7, pp. 1385–1396, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. F. J. Castellino and V. A. Ploplis, “Structure and function of the plasminogen/plasmin system,” Thrombosis and Haemostasis, vol. 93, no. 4, pp. 647–654, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. E. F. Plow, L. Doeuvre, and R. Das, “So many plasminogen receptors: why?” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 141806, 6 pages, 2012. View at Publisher · View at Google Scholar
  60. J. Bürgin and J. Schaller, “Expression, isolation and characterization of a mutated human plasminogen kringle 3 with a functional lysine binding site,” Cellular and Molecular Life Sciences, vol. 55, no. 1, pp. 135–141, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. J. M. Marshall, A. J. Brown, and C. P. Ponting, “Conformational studies of human plasminogen and plasminogen fragments: evidence for a novel third conformation of plasminogen,” Biochemistry, vol. 33, no. 12, pp. 3599–3606, 1994. View at Publisher · View at Google Scholar · View at Scopus
  62. W. F. Mangel, B. Lin, and V. Ramakrishnan, “Characterization of an extremely large, ligand-induced conformational change in plasminogen,” Science, vol. 248, no. 4951, pp. 69–73, 1990. View at Publisher · View at Google Scholar · View at Scopus
  63. G. Markus, “Conformational changes in plasminogen, their effect on activation, and the agents that modulate activation rates —a review,” Fibrinolysis, vol. 10, no. 2, pp. 75–85, 1996. View at Publisher · View at Google Scholar · View at Scopus
  64. K. C. Robbins, L. Summaria, B. Hsieh, and R. J. Shah, “The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin,” The Journal of Biological Chemistry, vol. 242, no. 10, pp. 2333–2342, 1967. View at Google Scholar
  65. O. Saksela, “Plasminogen activation and regulation of pericellular proteolysis,” BBA-Reviews on Cancer, vol. 823, no. 1, pp. 35–65, 1985. View at Publisher · View at Google Scholar · View at Scopus
  66. J.-D. Vassalli, A.-P. Sappino, and D. Belin, “The plasminogen activator/plasmin system,” Journal of Clinical Investigation, vol. 88, no. 4, pp. 1067–1072, 1991. View at Publisher · View at Google Scholar · View at Scopus
  67. K. Danø, P. A. Andreasen, J. Grøndahl-Hansen, P. Kristensen, L. S. Nielsen, and L. Skriver, “Plasminogen activators, tissue degradation, and cancer,” Advances in Cancer Research, vol. 44, no. C, pp. 139–266, 1985. View at Publisher · View at Google Scholar · View at Scopus
  68. N. J. Mutch and N. A. Booth, “Plasmin-antiplasmin system,” Trauma Induced Coagulopathy, pp. 31–51, 2016. View at Publisher · View at Google Scholar · View at Scopus
  69. G. Cesarman-Maus and K. A. Hajjar, “Molecular mechanisms of fibrinolysis,” British Journal of Haematology, vol. 129, no. 3, pp. 307–321, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. L. C. Petersen, L. R. Lund, L. S. Nielsen, K. DanÃ, and L. Skriver, “One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity,” Journal of Biological Chemistry, vol. 263, no. 23, pp. 11189–11195, 1988. View at Google Scholar
  71. R. Pannell and V. Gurewich, “Activation of plasminogen by single-chain urokinase or by two-chain urokinase--a demonstration that single-chain urokinase has a low catalytic activity (pro-urokinase),” Blood, vol. 69, no. 1, article 22, 1987. View at Google Scholar
  72. P. Verde, M. P. Stoppelli, P. Galeffi, P. Di Nocera, and F. Blasi, “Identification and primary sequence of an unspliced human urokinase Poly(A)+RNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 81, no. 15, pp. 4727–4731, 1984. View at Google Scholar
  73. M. Nobuhara, M. Sakamaki, H. Ohnishi, and Y. Suzuki, “A comparative study of high molecular weight urokinase and low molecular weight urokinase,” Journal of Biochemistry, vol. 90, no. 1, pp. 225–232, 1981. View at Publisher · View at Google Scholar · View at Scopus
  74. M. E. van der, D. C. Kaaden, T. J. C. van Berkel, and J. Kuiper, “Plasma clearance of urokinase-type plasminogen activator,” Fibrinolysis & Proteolysis, vol. 12, no. 4, pp. 251–258, 1998. View at Google Scholar
  75. Q. Huai, A. P. Mazar, A. Kuo et al., “Structure of human urokinase plasminogen activator in complex with its receptor,” Science, vol. 311, no. 5761, pp. 656–659, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. M. P. Stoppelli, A. Corti, A. Soffientini, G. Cassani, F. Blasi, and R. K. Assoian, “Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 15, pp. 4939–4943, 1985. View at Publisher · View at Google Scholar · View at Scopus
  77. A. L. Roldan, M. V. Cubellis, M. T. Masucci et al., “Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis,” The EMBO Journal, vol. 9, no. 2, pp. 467–474, 1990. View at Google Scholar
  78. J. D. Vassalli, D. Baccino, and D. Belin, “A Cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase,” The Journal of Cell Biology, vol. 100, no. 1, pp. 86–92, 1985. View at Google Scholar
  79. K. M. Baeten, M. C. Richard, S. M. Kanse, N. J. Mutch, J. L. Degen, and N. A. Booth, “Activation of single-chain urokinase-type plasminogen activator by platelet-associated plasminogen: a mechanism for stimulation of fibrinolysis by platelets,” Journal of Thrombosis and Haemostasis, vol. 8, no. 6, pp. 1313–1322, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. N. Manchanda and B. S. Schwartz, “Single chain urokinase. augmentation of enzymatic activity upon binding to monocytes,” Journal of Biological Chemistry, vol. 266, no. 22, pp. 14580–14584, 1991. View at Google Scholar
  81. M. V. Carriero, P. Franco, I. Vocca et al., “Structure, function and antagonists of urokinase-type plasminogen activator,” Frontiers in Bioscience, vol. 14, no. 10, pp. 3782–3794, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. P. Carmeliet, L. Schoonjans, L. Kieckens et al., “Physiological consequences of loss of plasminogen activator gene function in mice,” Nature, vol. 368, no. 6470, pp. 419–424, 1994. View at Publisher · View at Google Scholar · View at Scopus
  83. T. H. Bugge, M. J. Flick, M. J. S. Danton et al., “Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 12, pp. 5899–5904, 1996. View at Publisher · View at Google Scholar · View at Scopus
  84. J. Hansen, B. Svensson, C. Zhang, V. Lyngmo, and A. Nordoy, “asal plasma concentration of tissue plasminogen activator (t-PA) and the adaption to strenuous exercise in familial hypercholesterolaemia (FH),” Blood Coagulation and Fibrinolysis, vol. 5, no. 5, pp. 781–787, 1994. View at Google Scholar
  85. E. L. Madison, “Probing structure-function relationships of tissue-type plasminogen activator by site-specific mutagenesis,” Fibrinolysis and Proteolysis, vol. 8, no. 1, pp. 221–236, 1994. View at Publisher · View at Google Scholar · View at Scopus
  86. C. de Vries, H. Veerman, M. E. Nesheim, and H. Pannekoek, “Kinetic characterization of tissue-type plasminogen activator (t-PA) and t-PA deletion mutants,” Thrombosis and Haemostasis, vol. 65, no. 3, pp. 280–285, 1991. View at Google Scholar
  87. E. Suenson, O. Lützen, and S. Thorsen, “Initial plasmin‐degradation of fibrin as the basis of a positive feed‐back mechanism in fibrinolysis,” European Journal of Biochemistry, vol. 140, no. 3, pp. 513–522, 1984. View at Publisher · View at Google Scholar · View at Scopus
  88. E. Suenson, P. Bjerrum, A. Holm et al., “The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation,” Journal of Biological Chemistry, vol. 265, no. 36, pp. 22228–22237, 1990. View at Google Scholar
  89. B. Norrman, P. Wallén, and M. Rånby, “Fibrinolysis mediated by tissue plasminogen activator: disclosure of a kinetic transition,” European Journal of Biochemistry, vol. 149, no. 1, pp. 193–200, 1985. View at Publisher · View at Google Scholar · View at Scopus
  90. D. Lamba, M. Bauer, R. Huber et al., “The 2.3 Å crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator,” Journal of Molecular Biology, vol. 258, no. 1, pp. 117–135, 1996. View at Publisher · View at Google Scholar · View at Scopus
  91. P. Grailhe, W. Nieuwenhuizen, and E. Anglés‐Cano, “Study of tissue‐type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogen,” European Journal of Biochemistry, vol. 219, no. 3, pp. 961–967, 1994. View at Publisher · View at Google Scholar · View at Scopus
  92. R. A. Burton, G. Tsurupa, R. R. Hantgan, N. Tjandra, and L. Medved, “NMR solution structure, stability, and interaction of the recombinant bovine fibrinogen αC-domain fragment,” Biochemistry, vol. 46, no. 29, pp. 8550–8560, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. C. Longstaff, C. Thelwell, S. C. Williams, M. M. C. G. Silva, L. Szabó, and K. Kolev, “The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies,” Blood, vol. 117, no. 2, pp. 661–668, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. M. M. C. G. Silva, C. Thelwell, S. C. Williams, and C. Longstaff, “Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator,” Journal of Thrombosis and Haemostasis, vol. 10, no. 11, pp. 2354–2360, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. J. Schaller and S. S. Gerber, “The plasmin-antiplasmin system: structural and functional aspects,” Cellular and Molecular Life Sciences, vol. 68, no. 5, pp. 785–801, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. B. Wiman, L. Boman, and D. Collen, “On the kinetics of the reaction between human antiplasmin and a low‐molecular‐weight form of plasmin,” European Journal of Biochemistry, vol. 87, no. 1, pp. 143–146, 1978. View at Publisher · View at Google Scholar · View at Scopus
  97. W. E. Holmes, L. Nelles, H. R. Lijnen, and D. Collen, “Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin),” Journal of Biological Chemistry, vol. 262, no. 4, pp. 1659–1664, 1987. View at Google Scholar
  98. S. R. Fraser, N. A. Booth, and N. J. Mutch, “The antifibrinolytic function of factor XIII is exclusively expressed through α2-antiplasmin cross-linking,” Blood, vol. 117, no. 23, pp. 6371–6374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. G. Tsurupa, S. Yakovlev, P. McKee, and L. Medved, “Noncovalent interaction of α2-antiplasmin with fibrin(ogen): localization of α2-antiplasmin-binding sites,” Biochemistry, vol. 49, no. 35, pp. 7643–7651, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. R. H. P. Law, T. Sofian, W. Kan et al., “X-ray crystal structure of the fibrinolysis inhibitor alpha2-antiplasmin,” Blood, vol. 111, no. 4, pp. 2049–2052, 2008. View at Google Scholar
  101. T. Sasaki, T. Morita, and S. Iwanaga, “Identification of the plasminogen-binding site of human alpha 2-plasmin inhibitor,” Journal of Biochemistry, vol. 99, no. 6, pp. 1699–1705, 1986. View at Google Scholar
  102. C. M. Hekman and D. J. Loskutoff, “Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator,” Archives of Biochemistry and Biophysics, vol. 262, no. 1, pp. 199–210, 1988. View at Publisher · View at Google Scholar · View at Scopus
  103. E. L. Madison, E. J. Goldsmith, R. D. Gerard, M.-J. H. Gething, and J. F. Sambrook, “Serpin-resistant mutants of human tissue-type plasminogen activator,” Nature, vol. 339, no. 6227, pp. 721–724, 1989. View at Publisher · View at Google Scholar · View at Scopus
  104. L. A. Erickson, M. H. Ginsberg, and D. J. Loskutoff, “Detection and partial characterization of an inhibitor of plasminogen activator in human platelets,” Journal of Clinical Investigation, vol. 74, no. 4, pp. 1465–1472, 1984. View at Publisher · View at Google Scholar · View at Scopus
  105. P. Mikus, T. Urano, P. Liljeström, and T. Ny, “Plasminogen‐activator inhibitor type 2 (PAI‐2) is a spontaneously polymerising SERPIN: biochemical characterisation of the recombinant intracellular and extracellular forms,” European Journal of Biochemistry, vol. 218, no. 3, pp. 1071–1082, 1993. View at Publisher · View at Google Scholar · View at Scopus
  106. M. Nesheim, “Fibrinolysis and the plasma carboxypeptidase,” Current Opinion in Hematology, vol. 5, no. 5, pp. 309–313, 1998. View at Publisher · View at Google Scholar · View at Scopus
  107. D. L. Eaton, B. E. Malloy, S. P. Tsai, W. Henzel, and D. Drayna, “Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma,” Journal of Biological Chemistry, vol. 266, no. 32, pp. 21833–21838, 1991. View at Google Scholar
  108. W. Wang, M. B. Boffa, L. Bajzar, J. B. Walker, and M. E. Nesheim, “A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor,” Journal of Biological Chemistry, vol. 273, no. 42, pp. 27176–27181, 1998. View at Publisher · View at Google Scholar · View at Scopus
  109. D. V. Sakharov, E. F. Plow, and D. C. Rijken, “On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B,” Journal of Biological Chemistry, vol. 272, no. 22, pp. 14477–14482, 1997. View at Publisher · View at Google Scholar · View at Scopus
  110. E. A. Ryan, L. F. Mockros, J. W. Weisel, and L. Lorand, “Structural origins of fibrin clot rheology,” Biophysical Journal, vol. 77, no. 5, pp. 2813–2826, 1999. View at Publisher · View at Google Scholar · View at Scopus
  111. M. E. Carr Jr and B. M. Alving, “Effect of fibrin structure on plasmin-mediated dissolution of plasma clots,” Blood Coagulation & Fibrinolysis, vol. 6, no. 6, pp. 567–573, 1995. View at Google Scholar
  112. K. R. Machlus, J. C. Cardenas, F. C. Church, and A. S. Wolberg, “Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice,” Blood, vol. 117, no. 18, pp. 4953–4963, 2011. View at Publisher · View at Google Scholar · View at Scopus
  113. R. A. Campbell, K. A. Overmyer, C. R. Bagnell, and A. S. Wolberg, “Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 12, pp. 2247–2254, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. P. A. Janmey, E. J. Amis, and J. D. Ferry, “Rheology of fibrin clots. VI. Stress relaxation, creep, and differential dynamic modulus of fine clots in large shearing deformations,” Journal of Rheology, vol. 27, no. 2, pp. 135–153, 1983. View at Publisher · View at Google Scholar · View at Scopus
  115. W. W. Roberts, O. Kramer, R. W. Rosser, F. H. M. Nestler, and J. D. Ferry, “Rheology of fibrin clots. I. Dynamic viscoelastic properties and fluid permeation,” Biophysical Chemistry, vol. 1, no. 3, pp. 152–160, 1974. View at Publisher · View at Google Scholar · View at Scopus
  116. D. A. Gabriel, K. Muga, and E. M. Boothroyd, “The effect of fibrin structure on fibrinolysis,” Journal of Biological Chemistry, vol. 267, no. 34, article 24259, 1992. View at Google Scholar
  117. A. Blinc, J. Magdic, J. Fric, and I. Musevic, “Atomic force microscopy of fibrin networks and plasma clots during fibrinolysis,” Fibrinolysis & Proteolysis, vol. 14, no. 5, pp. 288–299, 2000. View at Google Scholar
  118. S. L. Diamond and S. Anand, “Inner clot diffusion and permeation during fibrinolysis,” Biophysical Journal, vol. 65, no. 6, pp. 2622–2643, 1993. View at Publisher · View at Google Scholar · View at Scopus
  119. J. W. Weisel, “Structure of fibrin: impact on clot stability,” Journal of Thrombosis and Haemostasis, vol. 5, no. 1, pp. 116–124, 2007. View at Publisher · View at Google Scholar · View at Scopus
  120. J. P. Collet, D. Park, C. Lesty et al., “Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed dynamic and structural approaches by confocal microscopy,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 5, pp. 1354–1361, 2000. View at Publisher · View at Google Scholar · View at Scopus
  121. I. Bucay, E. T. O'Brien, S. D. Wulfe et al., “Physical determinants of fibrinolysis in single fibrin fibers,” PLoS ONE, vol. 10, no. 2, Article ID e0116350, 2015. View at Publisher · View at Google Scholar · View at Scopus
  122. Y. Veklich, C. W. Francis, J. White, and J. W. Weisel, “Structural studies of fibrinolysis by electron microscopy,” Blood, vol. 92, no. 12, article 4721, 1998. View at Google Scholar
  123. J.-P. Collet, C. Lesty, G. Montalescot, and J. W. Weisel, “Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots,” Journal of Biological Chemistry, vol. 278, no. 24, pp. 21331–21335, 2003. View at Publisher · View at Google Scholar · View at Scopus
  124. D. V. Sakharov and D. C. Rijken, “Superficial accumulation of plasminogen during plasma clot lysis,” Circulation, vol. 92, no. 7, pp. 1883–1890, 1995. View at Publisher · View at Google Scholar · View at Scopus
  125. R. A. Campbell, K. A. Overmyer, C. H. Selzman, B. C. Sheridan, and A. S. Wolberg, “Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability,” Blood, vol. 114, no. 23, pp. 4886–4896, 2009. View at Publisher · View at Google Scholar · View at Scopus
  126. K. Kolev, K. Tenekedjiev, E. Komorowicz, and R. Machovich, “Functional evaluation of the structural features of proteases and their substrate in fibrin surface degradation,” Journal of Biological Chemistry, vol. 272, no. 21, pp. 13666–13675, 1997. View at Publisher · View at Google Scholar · View at Scopus
  127. J. P. Collet, J. Soria, M. Mirshahi et al., “Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure,” Blood, vol. 82, no. 8, pp. 2462–2469, 1993. View at Google Scholar
  128. K. Fatah, A. Silveira, P. Tornvall, F. Karpe, M. Blombäck, and A. Hamsten, “Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age,” Thrombosis and Haemostasis, vol. 76, no. 4, pp. 535–540, 1996. View at Google Scholar
  129. L. Muszbek, Z. Bagoly, Z. Bereczky, and E. Katona, “The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis,” Cardiovascular & Hematological Agents in Medicinal Chemistry, vol. 6, no. 3, pp. 190–205, 2008. View at Google Scholar
  130. C. S. Greenberg and C. C. Miraglia, “The effect of fibrin polymers on thrombin-catalyzed plasma factor XIIIa formation,” Blood, vol. 66, no. 2, article 466, 1985. View at Google Scholar
  131. L. Muszbek, J. Polgár, and Z. Boda, “Platelet factor XIII becomes active without the release of activation peptide during platelet activation,” Thrombosis and Haemostasis, vol. 69, no. 3, pp. 282–285, 1993. View at Google Scholar
  132. D. C. Rijken, S. Abdul, J. J. Malfliet, F. W. Leebeek, and S. Uitte de Willige, “Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII,” Journal of Thrombosis and Haemostasis, vol. 14, no. 7, pp. 1453–1461, 2016. View at Google Scholar
  133. K. N. Lee, K. W. Jackson, and P. A. McKee, “Effect of a synthetic carboxy-terminal peptide of α2-antiplasmin on urokinase-induced fibrinolysis,” Thrombosis Research, vol. 105, no. 3, pp. 263–270, 2002. View at Publisher · View at Google Scholar · View at Scopus
  134. Y. Sakata and N. Aoki, “Cross-linking of α2-plasmin inhibitor to fibrin by fibrin-stabilizing factor,” Journal of Clinical Investigation, vol. 65, no. 2, pp. 290–297, 1980. View at Publisher · View at Google Scholar · View at Scopus
  135. Y. Sakata and N. Aoki, “Significance of cross-linking of α2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis,” Journal of Clinical Investigation, vol. 69, no. 3, pp. 536–542, 1982. View at Publisher · View at Google Scholar · View at Scopus
  136. P. H. Jensen, L. Lorand, P. Ebbesen, and J. Gliemann, “Type‐2 plasminogen‐activator inhibitor is a substrate for trophoblast transglutaminase and Factor XIIIa Transglutaminase‐catalyzed cross‐linking to cellular and extracellular structures,” European Journal of Biochemistry, vol. 214, no. 1, pp. 141–146, 1993. View at Publisher · View at Google Scholar · View at Scopus
  137. Z. Valnickova and J. J. Enghild, “Human procarboxypeptidase U, or thrombin-activable fibrinolysis inhibitor, is a substrate for transglutaminases: evidence for transglutaminase-catalyzed cross-linking to fibrin,” Journal of Biological Chemistry, vol. 273, no. 42, pp. 27220–27224, 1998. View at Publisher · View at Google Scholar · View at Scopus
  138. J. McDonagh and H. Fukue, “Determinants of substrate specificity for factor XIII,” Seminars in Thrombosis and Hemostasis, vol. 22, no. 5, pp. 369–376, 1996. View at Publisher · View at Google Scholar · View at Scopus
  139. L. Purves, M. Purves, and W. Brandt, “Cleavage of fibrin-derived D-dimer into monomers by endopeptidase from puff adder venom (Bitis arietans) acting at cross-linked sites of the gamma-chain. Sequence of carboxy-terminal cyanogen bromide gamma-chain fragments,” Biochemistry, vol. 26, no. 15, pp. 4640–4646, 1987. View at Google Scholar
  140. C. Duval, P. Allan, S. D. A. Connell, V. C. Ridger, H. Philippou, and R. A. S. Ariëns, “Roles of fibrin α- and γ-chain specific cross-linking by FXIIIa in fibrin structure and function,” Thrombosis and Haemostasis, vol. 111, no. 5, pp. 842–850, 2014. View at Publisher · View at Google Scholar · View at Scopus
  141. K. F. Standeven, A. M. Carter, P. J. Grant et al., “Functional analysis of fibrin γ-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness,” Blood, vol. 110, no. 3, pp. 902–907, 2007. View at Publisher · View at Google Scholar · View at Scopus
  142. R. Chen and R. F. Doolittle, “γ-γ Cross-linking sites in human and bovine fibrin,” Biochemistry, vol. 10, no. 24, pp. 4487–4491, 1971. View at Google Scholar
  143. K. N. Mouapi, J. D. Bell, K. A. Smith, R. A. S. Ariëns, H. Philippou, and M. C. Maurer, “Ranking reactive glutamines in the fibrinogen aC region that are targeted by blood coagulant factor XIII,” Blood, vol. 127, no. 18, pp. 2241–2248, 2016. View at Google Scholar
  144. J. H. Sobel and M. A. Gawinowicz, “Identification of the α chain lysine donor sites involved in factor XIII(a) fibrin cross-linking,” Journal of Biological Chemistry, vol. 271, no. 32, pp. 19288–19297, 1996. View at Publisher · View at Google Scholar · View at Scopus
  145. W. Wang, “Identification of respective lysine donor and glutamine acceptor sites involved in factor XIIIa-catalyzed fibrin α chain cross-linking,” Journal of Biological Chemistry, vol. 286, no. 52, pp. 44952–44964, 2011. View at Publisher · View at Google Scholar · View at Scopus
  146. Y. V. Matsuka, L. V. Medved, M. M. Migliorini, and K. C. Ingham, “Factor XIIIA-catalyzed cross-linking of recombinant αC fragments of human fibrinogen,” Biochemistry, vol. 35, no. 18, pp. 5810–5816, 1996. View at Publisher · View at Google Scholar · View at Scopus
  147. E. L. Hethershaw, A. L. Cilia La Corte, C. Duval et al., “The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis,” Journal of Thrombosis and Haemostasis, vol. 12, no. 2, pp. 197–205, 2014. View at Publisher · View at Google Scholar · View at Scopus
  148. M. W. Rampling and C. Flexman, “Factor XIII cross-linking and fibrinolytic rates,” Thrombosis Research, vol. 16, no. 5-6, pp. 877–880, 1979. View at Publisher · View at Google Scholar · View at Scopus
  149. P. J. Gaffney and A. N. Whitaker, “Fibrin crosslinks and lysis rates,” Thrombosis Research, vol. 14, no. 1, pp. 85–94, 1979. View at Publisher · View at Google Scholar · View at Scopus
  150. M. W. Rampling, “Factor XIII cross-linking and the rate of fibrinolysis induced by streptokinase and urokinase,” Thrombosis Research, vol. 12, no. 2, pp. 287–295, 1978. View at Publisher · View at Google Scholar · View at Scopus
  151. C. W. Francis and V. J. Marder, “Increased resistance to plasmic degradation of fibrin with highly crosslinked alpha-polymer chains formed at high factor XIII concentrations,” Blood, vol. 71, no. 5, article 1361, 1988. View at Google Scholar
  152. N. A. Kurniawan, J. Grimbergen, J. Koopman, and G. H. Koenderink, “Factor XIII stiffens fibrin clots by causing fiber compaction,” Journal of Thrombosis and Haemostasis, vol. 12, no. 10, pp. 1687–1696, 2014. View at Publisher · View at Google Scholar · View at Scopus
  153. K. R. Siebenlist and M. W. Mosesson, “Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis,” Journal of Biological Chemistry, vol. 269, no. 45, pp. 28414–28419, 1994. View at Google Scholar
  154. J. R. Houser, N. E. Hudson, L. Ping et al., “Evidence that αC region is origin of low modulus, high extensibility, and strain stiffening in fibrin fibers,” Biophysical Journal, vol. 99, no. 9, pp. 3038–3047, 2010. View at Publisher · View at Google Scholar · View at Scopus
  155. W. Liu, C. R. Carlisle, E. A. Sparks, and M. Guthold, “The mechanical properties of single fibrin fibers,” Journal of Thrombosis and Haemostasis, vol. 8, no. 5, pp. 1030–1036, 2010. View at Publisher · View at Google Scholar · View at Scopus
  156. C. C. Helms, R. A. S. Ariëns, S. Uitte De Willige, K. F. Standeven, and M. Guthold, “α-α Cross-links increase fibrin fiber elasticity and stiffness,” Biophysical Journal, vol. 102, no. 1, pp. 168–175, 2012. View at Publisher · View at Google Scholar · View at Scopus
  157. M. M. Aleman, J. R. Byrnes, and J. G. Wang, “Factor XIII activity mediates red blood cell retention in venous thrombi,” The Journal of Clinical Investigation, vol. 124, pp. 3590–3600, 2014. View at Publisher · View at Google Scholar
  158. J. R. Byrnes, C. Duval, Y. Wang et al., “Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking,” Blood, vol. 126, no. 16, pp. 1940–1948, 2015. View at Publisher · View at Google Scholar · View at Scopus
  159. L. Shen and L. Lorand, “Contribution of fibrin stabilization to clot strength. Supplementation of factor XIII-deficient plasma with the purified zymogen,” Journal of Clinical Investigation, vol. 71, no. 5, pp. 1336–1341, 1983. View at Publisher · View at Google Scholar · View at Scopus
  160. W. S. Hur, N. Mazinani, X. J. D. Lu et al., “Coagulation factor XIIIa is inactivated by plasmin,” Blood, vol. 126, no. 20, pp. 2329–2337, 2015. View at Publisher · View at Google Scholar · View at Scopus
  161. A. Blinc and C. W. Francis, “Transport processes in fibrinolysis and fibrinolytic therapy,” Thrombosis and Haemostasis, vol. 76, no. 4, pp. 481–491, 1996. View at Google Scholar
  162. A. S. Wolberg, “Plasma and cellular contributions to fibrin network formation, structure and stability,” Haemophilia, vol. 16, no. 3, pp. 7–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  163. N. Wohner, P. Sótonyi, R. MacHovich et al., “Lytic resistance of fibrin containing red blood cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 10, pp. 2306–2313, 2011. View at Publisher · View at Google Scholar · View at Scopus
  164. A. R. Wufsus, N. E. MacEra, and K. B. Neeves, “The hydraulic permeability of blood clots as a function of fibrin and platelet density,” Biophysical Journal, vol. 104, no. 8, pp. 1812–1823, 2013. View at Publisher · View at Google Scholar · View at Scopus
  165. M. Y. Matveyev and S. P. Domogatsky, “Penetration of macromolecules into contracted blood clot,” Biophysical Journal, vol. 63, no. 3, pp. 862-863, 1992. View at Publisher · View at Google Scholar · View at Scopus
  166. A. S. Adhikari, A. H. Mekhdjian, and A. R. Dunn, “Strain tunes proteolytic degradation and diffusive transport in fibrin networks,” Biomacromolecules, vol. 13, no. 2, pp. 499–506, 2012. View at Publisher · View at Google Scholar · View at Scopus
  167. C. Craig Blackmore, C. W. Francis, R. G. Bryant, B. Brenner, and V. J. Marder, “Magnetic resonance imaging of blood and clots in vitro,” Investigative Radiology, vol. 25, no. 12, pp. 1316–1324, 1990. View at Publisher · View at Google Scholar · View at Scopus
  168. J. H. Wu, K. Siddiqui, and S. L. Diamond, “Transport phenomena and clot dissolving therapy: an experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis,” Thrombosis and Haemostasis, vol. 72, no. 1, pp. 105–112, 1994. View at Google Scholar
  169. A. Blinc, G. Planinsic, D. Keber et al., “Dependence of blood clot lysis on the mode of transport of urokinase into the clot--a magnetic resonance imaging study in vitro,” Thrombosis and Haemostasis, vol. 65, no. 5, pp. 549–552, 1991. View at Google Scholar
  170. F. Bajd, J. Vidmar, A. Blinc, and I. Serša, “Microscopic clot fragment evidence of biochemo-mechanical degradation effects in thrombolysis,” Thrombosis Research, vol. 126, no. 2, pp. 137–143, 2010. View at Publisher · View at Google Scholar · View at Scopus
  171. A. Piebalgs and X. Y. Xu, “Towards a multi-physics modelling framework for thrombolysis under the influence of blood flow,” Journal of the Royal Society Interface, vol. 12, no. 113, Article ID 20150949, 2015. View at Publisher · View at Google Scholar · View at Scopus
  172. M. Guthold, W. Liu, E. A. Sparks et al., “A comparison of the mechanical and structural properties of fibrin fibers with other protein fibers,” Cell Biochemistry and Biophysics, vol. 49, no. 3, pp. 165–181, 2007. View at Publisher · View at Google Scholar · View at Scopus
  173. K. C. Gersh, K. E. Edmondson, and J. W. Weisel, “Flow rate and fibrin fiber alignment,” Journal of Thrombosis and Haemostasis, vol. 8, no. 12, pp. 2826–2828, 2010. View at Publisher · View at Google Scholar · View at Scopus
  174. R. A. Campbell, M. M. Aleman, L. D. Gray, M. R. Falvo, and A. S. Wolberg, “Flow profoundly influences fibrin network structure: implications for fibrin formation and clot stability in haemostasis,” Thrombosis and Haemostasis, vol. 104, no. 6, pp. 1281–1284, 2010. View at Publisher · View at Google Scholar · View at Scopus
  175. P. Whittaker and K. Przyklenk, “Fibrin architecture in clots: a quantitative polarized light microscopy analysis,” Blood Cells, Molecules, and Diseases, vol. 42, no. 1, pp. 51–56, 2009. View at Publisher · View at Google Scholar · View at Scopus
  176. I. Cohen, J. M. Gerrard, and J. G. White, “Ultrastructure of clots during isometric contraction,” The Journal of Cell Biology, vol. 93, no. 3, pp. 775–787, 1982. View at Google Scholar
  177. W. A. Lam, O. Chaudhuri, A. Crow et al., “Mechanics and contraction dynamics of single platelets and implications for clot stiffening,” Nature Materials, vol. 10, no. 1, pp. 61–66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  178. M. R. Falvo, O. V. Gorkun, and S. T. Lord, “The molecular origins of the mechanical properties of fibrin,” Biophysical Chemistry, vol. 152, no. 1–3, pp. 15–20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  179. M. R. Falvo, D. Millard, E. T. O'Brien III, R. Superfine, and S. T. Lord, “Length of tandem repeats in fibrin's αC region correlates with fiber extensibility,” Journal of Thrombosis and Haemostasis, vol. 6, no. 11, pp. 1991–1993, 2008. View at Publisher · View at Google Scholar · View at Scopus
  180. R. D. Averett, B. Menn, E. H. Lee, C. C. Helms, T. Barker, and M. Guthold, “A modular fibrinogen model that captures the stress-strain behavior of fibrin fibers,” Biophysical Journal, vol. 103, no. 7, pp. 1537–1544, 2012. View at Publisher · View at Google Scholar · View at Scopus
  181. A. E. X. Brown, R. I. Litvinov, D. E. Discher, and J. W. Weisel, “Forced unfolding of coiled-coils in fibrinogen by single-molecule AFM,” Biophysical Journal, vol. 92, no. 5, pp. L39–L41, 2007. View at Publisher · View at Google Scholar · View at Scopus
  182. A. Zhmurov, O. Kononova, R. I. Litvinov, R. I. Dima, V. Barsegov, and J. W. Weisel, “Mechanical transition from α-helical coiled coils to β-sheets in fibrin(ogen),” Journal of the American Chemical Society, vol. 134, no. 50, pp. 20396–20402, 2012. View at Publisher · View at Google Scholar · View at Scopus
  183. B. B. C. Lim, E. H. Lee, M. Sotomayor, and K. Schulten, “Molecular basis of fibrin clot elasticity,” Structure, vol. 16, no. 3, pp. 449–459, 2008. View at Publisher · View at Google Scholar · View at Scopus
  184. L. E. Averett, C. B. Geer, R. R. Fuierer, B. B. Akhremitchev, O. V. Gorkun, and M. H. Schoenfisch, “Complexity of ‘A-a’ knob-hole fibrin interaction revealed by atomic force spectroscopy,” Langmuir, vol. 24, no. 9, pp. 4979–4988, 2008. View at Publisher · View at Google Scholar · View at Scopus
  185. M. Sabovic, H. R. Lijnen, D. Keber, and D. Collen, “Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators,” Thrombosis and Haemostasis, vol. 62, no. 4, pp. 1083–1087, 1989. View at Google Scholar
  186. D. B. Cines, T. Lebedeva, C. Nagaswami et al., “Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin,” Blood, vol. 123, no. 10, pp. 1596–1603, 2014. View at Publisher · View at Google Scholar · View at Scopus
  187. M. Weiner, “Clot retraction and fibrinolysis,” Clinical Chemistry, vol. 9, no. 2, article 182, 1963. View at Google Scholar
  188. J. Carr M, E. Martin, and S. Carr, “Delayed, reduced or inhibited thrombin production reduces platelet contractile force and results in weaker clot formation,” Blood Coagulation & Fibrinolysis, vol. 13, no. 3, pp. 193–197, 2002. View at Google Scholar
  189. S. Kunitada, G. A. FitzGerald, and D. J. Fitzgerald, “Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction,” Blood, vol. 79, no. 6, article 1420, 1992. View at Google Scholar
  190. J. V. Braaten, W. G. Jerome, and R. R. Hantgan, “Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface,” Blood, vol. 83, no. 4, article 982, 1994. View at Google Scholar
  191. J. P. Collet, G. Montalescot, C. Lesty, and J. W. Weisel, “A structural and dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots,” Circulation Research, vol. 90, no. 4, pp. 428–434, 2002. View at Publisher · View at Google Scholar · View at Scopus
  192. B. E. Sobel, D. A. Nachowiak, E. T. A. Fry, S. R. Bergmann, and S. R. Torr, “Paradoxical attenuation of fibrinolysis attributable to ‘plasminogen steal’ and its implications for coronary thrombolysis,” Coronary Artery Disease, vol. 1, no. 1, pp. 111–119, 1990. View at Publisher · View at Google Scholar · View at Scopus
  193. R. Gottlob, B. el-Nashef, P. Donas, F. Piza, and R. Kolb, “Studies on thrombolysis with streptokinase. IV. Immunofluorescent investigations on the fibrin pattern and the content of plasminogen and of plasma-plasmin-inhibitors in clots and thrombi of various age,” Thrombosis et Diathesis Haemorrhagica, vol. 29, no. 2, pp. 393–407, 1973. View at Google Scholar
  194. G. L. Reed, G. R. Matsueda, and E. Haber, “Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin,” Thrombosis and Haemostasis, vol. 68, no. 3, pp. 315–320, 1992. View at Google Scholar
  195. N. Aoki, “Clot retraction increases clot resistance to fibrinolysis by condensing alpha 2-plasmin inhibitor crosslinked to fibrin,” Thrombosis and Haemostasis, vol. 70, no. 2, article 376, 1993. View at Google Scholar
  196. E. Pósán, G. Ujj, A. Kiss, B. Telek, K. Rák, and M. Udvardy, “Reduced in vitro clot lysis and release of more active platelet PAI-1 in polycythemia vera and essential thrombocythemia,” Thrombosis Research, vol. 90, no. 2, pp. 51–56, 1998. View at Publisher · View at Google Scholar · View at Scopus
  197. T. Rusak, J. Piszcz, T. Misztal, J. Brańska-Januszewska, and M. Tomasiak, “Platelet-related fibrinolysis resistance in patients suffering from PV. Impact of clot retraction and isovolemic erythrocytapheresis,” Thrombosis Research, vol. 134, no. 1, pp. 192–198, 2014. View at Publisher · View at Google Scholar · View at Scopus
  198. E. T. O'Brien III, M. R. Falvo, D. Millard, B. Eastwood, R. M. Taylor II, and R. Superfine, “Ultrathin self-assembled fibrin sheets,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 49, pp. 19438–19443, 2008. View at Publisher · View at Google Scholar · View at Scopus
  199. C. Longstaff and K. Kolev, “Basic mechanisms and regulation of fibrinolysis,” Journal of Thrombosis and Haemostasis, vol. 13, supplement 1, pp. S98–S105, 2015. View at Publisher · View at Google Scholar · View at Scopus